Vaccine to prevent HIV may be available in about four yearsAnd this would help the immune system to produce antibodies that fight the virus, he told the agency on Tuesday. Any The infectologist and epidemiologist Jorge Sánchez.
Inside the frame 10 World Scientific Conference on HIV (IAS 2019) In Mexico City, the vice president of the Center for Technology, Biomedical and Environmental Research in Lima, Peru, said that the vaccine may be effective for various effects.
The idea is that with this new tool you can stop at least one 65% spread Of this epidemic.
"The vaccine has inserts from some parts that resemble parts of the virus, so the ability to be effective for different strains or types of HIV is high."Sanchez said, which is part of the research researcher.
The study is called mosaic and will be conducted by researchers from the National Institute of Allergic and Infectious Diseases, the National Institutions of Health, the HIV Vaccine Test Network and the United States. There. Army Medical Research and Development Command.
The investigation, which will begin in September, will be completed 3,800 people from Argentina, Brazil, Italy, Mexico, Peru, Poland, Spain and the United StatesOf 55 clinical locations around the world, 125 of them will be hosted by multiple cities.
The participants are people who have sex with men and transgender people.
"We are determined to develop an effective HIV vaccine worldwide to reduce the trajectory of the estimated 1.5 million new HIV infections per year."Larry Korean MD, Chief Scientist of HVTN," said Virolog and member of the Fred Hutchinson Cancer Research Center in Seattle.
The study reported that half of the patients would receive a placebo and the other half would be divided into four doses containing Adenovirus Serotype 20, which would provide mosquito antigens against HIV.
The antigens will serve to activate the immune response of the individual to the virus.
"This is not the virus as such, they are pieces of modified virus that will identify HIV and fight it so that it cannot reach any part of the body."Sanchez added.
The vaccine, said Sanchez, has already been tested in several phases in previous phases "And has results without major undesirable effects".
We have had a condom for decades, but the implementation is not enough, there is a prepositional prophylaxis (prep) and vaccine would be an additional tool"He said.
The vaccine study and development is sponsored by the pharmaceutical JanssenAnd although it is expected that within four years you can have clear results regarding its effectiveness, it is not yet considered to be publicly available.
With some information